Roger Clark

Charles River, England, United Kingdom

Roger is Head of High Throughput Screening (HTS) within Early Discovery at Charles River Labs (CRL). An experienced drug-discovery Bioscientist, Roger joined CRL in 2018 from AstraZeneca - where he had moved through various early discovery roles over ~19 years. His current remit sees him leading CRL’s HTS department - delivering assay development and execution of molecular target-based and phenotypic Hit ID campaigns for multiple client projects.

Over his pharmaceutical R&D career Roger has worked across many fields in early discovery including HTS, SAR Screening, High Content Biology and Laboratory Automation.

Disclosure information not submitted.

Presentation(s):

• Discovery: Innovation at Every Turn

  Monday, February 5, 2024
  12:00 PM – 1:00 PM EST